Clinical Trials Logo

Clinical Trial Summary

Our hypothesis is that improved line of sight to patient data, ergonomics, and headset lead shielding in the CCL will lead to behavioral changes in the CCL personnel that will reduce radiation exposure to all members of the team. Further, reducing the burden of large, cumbersome monitors will enable improved use of shielding. Our approach is a single center randomized controlled trial of consecutive patients randomly assigned to one of two groups with group 1 using mixed reality display and group 2 using standard 2D displays to perform diagnostic angiography in the CCL. Radiation exposure will be evaluated at multiple levels including total radiation exposure, exposure of each individual staff member, as well as specific exposure to eyes and head in group 1 versus group 2.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05063773
Study type Interventional
Source SG Devices LLC
Contact
Status Not yet recruiting
Phase N/A
Start date March 2023
Completion date March 2024

See also
  Status Clinical Trial Phase
Completed NCT04059809 - Photobiomodulation for Breast Cancer Radiodermatitis Phase 2/Phase 3
Completed NCT02985164 - Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography Phase 3
Recruiting NCT04152681 - Effect and Safety of Apatinib on Radiation-Induced Brain Injury Phase 2
Recruiting NCT04818099 - Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy Phase 3
Completed NCT03667859 - Vaginal Elasticity Assessment Before and After Brachytherapy/Pelvic Radiation
Completed NCT03660618 - LSFG-SKIN, Laser Speckle Flowgraphy N/A
Completed NCT00725244 - Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias Phase 4
Completed NCT00001523 - Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation N/A
Recruiting NCT03907371 - The Effect of Donepezil in Radiotherapy-related Cognitive Impairment. Phase 2
Completed NCT00001437 - Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis Phase 2
Recruiting NCT03208413 - The Therapeutic Effect of Thalidomide in RI Phase 2
Completed NCT02972736 - RadiatiOn Dose Among Different EndOvascular Procedures: the RODEO Study N/A
Completed NCT02104271 - Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial. Phase 2
Terminated NCT00134628 - Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue Injuries Phase 3
Completed NCT03961217 - Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes